A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/2004
11/11/2004	WO2004096751A1 Halogen substituted 3,3-diphenylpropylamines (tolterodine) having antimuscarinic activity
11/11/2004	WO2004096259A1 Methods and compositions using gonadotropin hormone releasing hormone
11/11/2004	WO2004096232A1 Interleukin-8 enhancer
11/11/2004	WO2004096213A1 Imidazolin-2-ylaminophenyl amides as ip antagonists
11/11/2004	WO2004096116A2 Diazabicyclononene derivatives
11/11/2004	WO2004038407A3 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12)
11/11/2004	US20040225123 Substituted phenyl naphthalenes as estrogenic agents
11/11/2004	US20040225118 31 human secreted proteins
11/11/2004	US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004	US20040225003 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies
11/11/2004	US20040224986 Piperidinyl targeting compounds that selectively bind integrins
11/11/2004	US20040224980 Compounds used as drugs in solvents as analgesics
11/11/2004	US20040224973 Substituted indoles as alpha-1 agonists
11/11/2004	US20040224969 Salts of substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid compounds
11/11/2004	US20040224966 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/11/2004	US20040224965 Treatment of cardiovascular disorders, thrombosis, surgery and nhe inhibitors
11/11/2004	US20040224954 Substituted 1H-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
11/11/2004	US20040224941 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/11/2004	US20040224929 Novel vitamin D analogs
11/11/2004	US20040224911 Transporters and ion channels
11/11/2004	US20040224902 Process for obtaining lignans
11/11/2004	US20040224885 Methods of treating hypertension and compositions for use therein
11/11/2004	US20040224877 drug delivery method of deglycosylated Vitamin D binding protein (DBP-maf) for angiogenesis inhibition; anticarcinogenic, antitumor agents
11/11/2004	US20040224360 Methods for diagnosing renal disorders
11/11/2004	US20040224356 Novel human enzymes of the metalloprotease family
11/11/2004	US20040224323 PAK5 screening methods
11/11/2004	US20040224314 G-protein coupled receptors
11/11/2004	US20040224023 Compositions and methods for treating or preventing diseases of body passageways
11/11/2004	CA2670067A1 Treatment of incontinence
11/11/2004	CA2523830A1 Methods and compositions using gonadotropin hormone releasing hormone
11/11/2004	CA2523763A1 Fused pyrimidine derivative
11/11/2004	CA2523226A1 Halogen substituted 3,3-diphenylpropylamines (tolterodine) having antimuscarinic activity
11/11/2004	CA2522817A1 Imidazolin-2-ylaminophenyl amides as ip antagonists
11/11/2004	CA2521951A1 Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors
11/11/2004	CA2521898A1 Diazabicyclononene derivatives
11/10/2004	EP1475386A2 Steroid nitrates for the treatment of oxidative injury and endothelial dysfunction
11/10/2004	EP1475103A1 Remedies for chronic kidney diseases
11/10/2004	EP1475099A1 Use of botulinum toxin to treat urinary incontinence
11/10/2004	EP1475087A2 A method for chemoprevention of prostate cancer
11/10/2004	EP1474528A2 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
11/10/2004	EP1474445A1 Glycoisoforms of adiponectin and uses thereof
11/10/2004	EP1474442A2 Cytotoxic t-cell epitopes from chlamydia
11/10/2004	EP1474438A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
11/10/2004	EP1474425A1 Deazapurines and uses thereof
11/10/2004	EP1474414A1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent
11/10/2004	EP1474405A2 Process for the preparation of 4-hetero-substituted phenylalanine derivatives
11/10/2004	EP1474403A2 Urea derivatives and their use as vanilloid receptor antagonists
11/10/2004	EP1474395A1 Nicotinamide derivates useful as p38 inhibitors
11/10/2004	EP1474150A2 Use of 2-alkoxyphenyl-substituted imidazotriazinones
11/10/2004	EP1474145A1 Quinoline derivatives as npy antagonists
11/10/2004	EP1474140A1 2-oxazolamines and their use as 5-ht2b receptor antagonists
11/10/2004	EP1474139A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/10/2004	EP1474137A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
11/10/2004	EP1474129A1 Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k
11/10/2004	EP1474127A1 Biphenyl derivatives and their use as antiandrogenic agents
11/10/2004	EP1474093A2 Granzyme b inhibitors
11/10/2004	EP1370560B1 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists
11/10/2004	EP1246793B1 Substituted aminomethyl-phenyl-cyclohexane derivatives
11/10/2004	EP0652868B1 INHIBITORS OF c-AMP PHOSPHODIESTERASE
11/10/2004	CN1545512A Rapamycin dialdehydes
11/10/2004	CN1545510A Quinazoline derivatives as alpha-1 adrenergic antagonists
11/10/2004	CN1545509A Piperidine derivatives useful as modulators of chemokine receptor activity
11/10/2004	CN1545413A Stabilized formulations of 6-hydroxy-3-(4-[piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof
11/10/2004	CN1544475A Sulfated Polyguluronic Acid Ester and its preparation method and uses
11/10/2004	CN1544461A Uro-genital condition treatment system
11/10/2004	CN1544043A Bunao Yishen Runchang Capsule for replenishing brain and kidney and moistening intestines
11/10/2004	CN1544042A Liuwei Dihuang dripping pills and its preparation
11/10/2004	CN1544037A Health care medicine capable of strengthening heart and kidney function and immunologic function
11/10/2004	CN1544029A Medicine for treating chronic kidney failure and its preparing process
11/10/2004	CN1544015A Kidney failure resistant formula and its preparation process
11/10/2004	CN1544008A Medicine for treating chronic nephritis and kidney disease and its preparation method
11/10/2004	CN1544000A Chuanshentong Injection for treating prostate proliferation and its preparation
11/10/2004	CN1543954A Tablet with controlled release of alfuzosine chlorhydrate
11/10/2004	CN1174981C Imidazole [1,2-A] pyridine and pyrazole [2,3-a] pyridine derivatives
11/10/2004	CN1174964C Vitamin D3 Analogs
11/10/2004	CN1174955C 3-amino-2-benzyl-1-phenyl-propane derivs.
11/10/2004	CN1174760C Application of saxifrage for preparing medicine for treating prostate hyperplasia
11/09/2004	US6815534 Tissue plasminogen activator-like protease
11/09/2004	US6815469 Injectable liquid oligomer-polymer composition consisting of at least one bioactive substance, at least one solid polymeric hydroxycarboxylic acid ester and at least one liquid oligomeric hydroxycarboxylic acid ester
11/09/2004	US6815463 For therapy of disease of cellular hyperproliferation in a subject
11/09/2004	US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/09/2004	US6815457 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin e-2,4-dione, maleic acid salt in polymorphic form
11/09/2004	US6815451 1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
11/09/2004	US6814985 Herbal compositions and uses for the treatment of allergic reactions
11/04/2004	WO2004094424A1 Nitrogen-containing heterocyclic compounds and use thereof
11/04/2004	WO2004093911A1 Pharmaceutical composition for prostatic disease treatment
11/04/2004	WO2004093852A2 Use of steroid derivatives for the treatment of angiotensin ii related disease e.g. cardiovascular and proliferative disorders
11/04/2004	WO2004093828A2 Reverse-turn mimetics and method relating thereto
11/04/2004	WO2004083245A3 Agent comprise an albumin-like first polypeptide bound to a second polypeptide
11/04/2004	WO2004069232A3 Egfr tyrosine kinase inhibitor for treating cardiovascular dysfunction
11/04/2004	WO2004067498A3 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/04/2004	WO2004066990A3 Methods of treating lower urinary tract disorders using sodium channel modulators
11/04/2004	WO2003090753A8 Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention
11/04/2004	WO2003077847A3 Substituted amides
11/04/2004	US20040220408 As anti-proliferative agents, therapy
11/04/2004	US20040220402 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
11/04/2004	US20040220247 N-[4-(4,5-Dihydro-1H-imidazol-2-yl-amino)-benzyl]-4-methoxy-benzamide and derivatives; prostaglandin inhibitors; urinary tract disease, disease related pain, neuropathic pain, respiratory asthma, allergy
11/04/2004	US20040220244 PHOSPHOLIPASE INHIBITORS; use of inhibitor compositions in mammals to relieve sick conditions accompanied by enhanced PLA(2) activity such as inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease
11/04/2004	US20040220230 transfroming growth factor antagonist; therapy for urogenital disorders, cardiovascular disorders
11/04/2004	US20040220225 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications

1 ... 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 ... 562